Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Tafluprost 15micrograms/ml eye dps 0.3ml ud preserv free
1106000AKAAAAAA
|
Tafluprost | Tafluprost | Eye | 13,196 |
|
Saflutan 15micrograms/ml eye drops 0.3ml unit dose
1106000AKBBAAAA
|
Saflutan | Tafluprost | Eye | 8,314 |
|
Tafluprost 15micrograms/ml eye drops
1106000AKAAABAB
|
Tafluprost | Tafluprost | Eye | 989 |
|
Saflutan 15micrograms/ml eye drops
1106000AKBBABAB
|
Saflutan | Tafluprost | Eye | 713 |
|
Taflotan 15micrograms/ml eye drops
1106000AKBCAAAB
|
Taflotan | Tafluprost | Eye | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.